Follow on Google News News By Tag Industry News * Pharmaceutical * More Industries... News By Place Country(s) Industry News
Follow on Google News | Jintropin® manufacturered by GeneScience Pharmaceuticals now available in Mexico.Mexico City, Mexico - September 16, 20111 - GeneScience Pharmaceuticals has received marketing approval for Jintropin® [somatropin (rDNA origin) for injection] under the brand name JTPN® Somatropina from the Secretaria De Salud.
By: GeneScience Pharmaceuticals JTPN ® Somatropina will now be available in pharmacies and hospitals throughout Mexico. "The quality and affordability of JTPN ® Somatropina will make it a popular product" says Ernesto Gomez manager at a Farmacias Similares drug store in Mexico City. About GeneScience Pharmaceuticals GeneScience Pharmaceuticals Co., Ltd. (GenSci) is the largest and most pofitable biopharmaceutical company in China focused on developing, manufacturing and marketing protein therapeutic products and biological supergenerics with special emphasis on endocrinology and related areas, aiming at providing affordable and innovative biopharmaceutical products to patients. GenSci is headquartered in Changchun, China, with 6 approved products on the market. GenSci's core product, GenLei® Jintropin™ (rhGH, somatropin for injection) has been the leading brand of rhGH in China with a dominant 70% of the market share. GenSci's profitability has been ranked No. 1 among Chinese biopharmaceutical companies. # # # About GeneScience Pharmaceuticals GeneScience Pharmaceuticals Co., Ltd. (GenSci) is the leading biopharmaceutical company in China focused on developing, manufacturing and marketing protein therapeutic products and biological supergenerics with special emphasis on endocrinology and related areas, aiming at providing affordable and innovative biopharmaceutical products to patients. GenSci is headquartered in Changchun, China, with 6 approved products on the market. GenSci's core product, GenLei® Jintropin™ (rhGH, somatropin for injection) has been the leading brand of rhGH in China with a dominant 70% of the market share. GenSci's profitability has been ranked No. 1 among Chinese biopharmaceutical companies. End
Account Phone Number Disclaimer Report Abuse
|
|